Journal article · 2025 · Open access

Therapeutic CD8 + T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound

María Betina Pampena, Sadia Samer, Elise G. Viox, Kevin Nguyen, Claire Deléage, Leticia Kuri-Cervantes, James Regan, Vincent H. Wu, Steffen S. Docken, Jeffrey T. Safrit, Katharine J. Bar, Brandon F. Keele and 3 more

Proceedings of the National Academy of Sciences, 122(33), e2501037122 · Published 14 August 2025 · DOI 10.1073/pnas.2501037122

Open PDFView at the publisherCite this paper

In brief

“Therapeutic CD8 + T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound” is a 2025 journal article by María Betina Pampena and 14 co-authors, published in Proceedings of the National Academy of Sciences. OpenAlex counts 7 citations as of 19 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Proceedings of the National Academy of Sciences.

Citations
7
Most cited in
2026 (6)
Field-weighted impact
2.06
References
61
Authors
15

Abstract

A primary obstacle for HIV elimination is the long-term viral reservoir in lymphoid tissues (LT) that can cause rebound viremia if therapy is stopped. Cytotoxic CD8 + T cells are critical for control of HIV and Simian immunodeficiency virus (SIV) viremia; however, CD8 + T cells that migrate to LT are primarily noncytotoxic, calling into question whether these cells could reduce the viral reservoir on antiretroviral therapy (ART) or control viral replication when therapy is halted. To determine whether CD8 + T cells can inhibit viral replication when retained in LT, we inhibited lymphocyte egress from LTs in ART-treated SIV-infected rhesus macaques (RMs) during analytic treatment interruption (ATI) using the S1PR modulator FTY720 alone or in combination with anti-PD1 antibody (αPD1) and the IL-15 receptor superagonist N-803 to increase cytolytic function. FTY720 retained migrating CD4 + and CD8 + T cells in LT, whereas cytotoxic CD8 + T cells remained in the vasculature. After ATI and viral rebound, activated SIV-specific CD8 + T cells increased in frequency in LT of FTY720-treated RMs but failed to become cytotoxic or control plasma viremia compared to controls, even when combined with αPD1 and N-803. These findings indicate that LT-localized CD8 + T cells alone may be insufficient to delay or prevent plasma viral rebound during ATI.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Pampena, M. B., Samer, S., Viox, E. G., Nguyen, K., Deléage, C., Kuri-Cervantes, L., Regan, J., Wu, V. H., Docken, S. S., Safrit, J. T., Bar, K. J., Keele, B. F., Davenport, M. P., Paiardini, M., & Betts, M. R. (2025). Therapeutic CD8 + T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound. Proceedings of the National Academy of Sciences, 122(33), e2501037122. https://doi.org/10.1073/pnas.2501037122

MLA 9

Pampena, María Betina, et al. “Therapeutic CD8 + T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound.” Proceedings of the National Academy of Sciences, vol. 122, no. 33, 2025, p. e2501037122. https://doi.org/10.1073/pnas.2501037122.

Chicago

Pampena, María Betina, Sadia Samer, Elise G. Viox, Kevin Nguyen, Claire Deléage, Leticia Kuri-Cervantes, James Regan, et al. 2025. “Therapeutic CD8 + T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound.” Proceedings of the National Academy of Sciences 122 (33): e2501037122. https://doi.org/10.1073/pnas.2501037122.

Harvard

Pampena, M. B. et al. (2025) ‘Therapeutic CD8 + T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound’, Proceedings of the National Academy of Sciences, 122(33), p. e2501037122. doi:10.1073/pnas.2501037122.

IEEE

M. B. Pampena et al., “Therapeutic CD8 + T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound,” Proceedings of the National Academy of Sciences, vol. 122, no. 33, p. e2501037122, 2025, doi: 10.1073/pnas.2501037122.

BibTeX

@article{pampena2025therapeutic,
  title     = {{Therapeutic CD8 + T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound}},
  author    = {Pampena, María Betina and Samer, Sadia and Viox, Elise G. and Nguyen, Kevin and Deléage, Claire and Kuri-Cervantes, Leticia and Regan, James and Wu, Vincent H. and Docken, Steffen S. and Safrit, Jeffrey T. and Bar, Katharine J. and Keele, Brandon F. and Davenport, Miles P. and Paiardini, Mirko and Betts, Michael R.},
  journal   = {Proceedings of the National Academy of Sciences},
  year      = {2025},
  volume    = {122},
  number    = {33},
  pages     = {e2501037122},
  doi       = {10.1073/pnas.2501037122},
  url       = {https://doi.org/10.1073/pnas.2501037122}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment

  • CD8+ T cells
  • tissue retention
  • lymphoid tissue
  • antiretroviral therapy interruption
  • viral reservoir
  • fingolimod
  • sphingosine-1-phosphate receptor
  • anti-PD-1

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Pampena, M. B., Samer, S., Viox, E. G., Nguyen, K., Deléage, C., Kuri-Cervantes, L., Regan, J., Wu, V. H., Docken, S. S., Safrit, J. T., Bar, K. J., Keele, B. F., Davenport, M. P., Paiardini, M., & Betts, M. R. (2025). Therapeutic CD8 + T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound. Proceedings of the National Academy of Sciences, 122(33), e2501037122. https://doi.org/10.1073/pnas.2501037122

How many times has this paper been cited?

7 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Proceedings of the National Academy of Sciences: sign in and open the PDF from this page.

Who wrote this paper?

María Betina Pampena, Sadia Samer, Elise G. Viox, Kevin Nguyen, Claire Deléage, Leticia Kuri-Cervantes, James Regan, Vincent H. Wu, Steffen S. Docken, Jeffrey T. Safrit, Katharine J. Bar, Brandon F. Keele and 3 more.

What is the DOI of this paper?

10.1073/pnas.2501037122, permanently at https://doi.org/10.1073/pnas.2501037122. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.